Third Harmonic Bio, Inc. (THRD) Financials

THRD Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2023 282.3 million 9.3 million
June 30, 2023 285.8 million 7.8 million
March 31, 2023 291.4 million 8.7 million
Dec. 31, 2022 298.7 million 9.6 million

THRD Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2023 -4.2 million 2.3 million
June 30, 2023 -4.1 million 2.8 million
March 31, 2023 -6.7 million 2.7 million
Dec. 31, 2022 -9.3 million 2.1 million

THRD Net Income

No data available :(

THRD Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2023 273.9 million - 4.1 million
June 30, 2023 278.1 million - 4.3 million
March 31, 2023 282.2 million - 4.4 million
Dec. 31, 2022 288.9 million - 4.3 million

THRD Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2023 39.7 million
June 30, 2023 39.6 million
March 31, 2023 22.8 million
Dec. 31, 2022 13.4 million

THRD Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2023 - 6.0 million 4.9 million -
June 30, 2023 168000 5.3 million 5.4 million -
March 31, 2023 168000 6.7 million 5.3 million -
Dec. 31, 2022 36000 9.3 million 4.3 million -

THRD Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2023 - 178000
June 30, 2023 - 168000
March 31, 2023 - 72000
Dec. 31, 2022 - 38000

THRD

Price: $5.38

52 week price:
3.18
16.02

Earnings Per Share: -1.24 USD

P/E Ratio: -4.34

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 101800

Market Capitalization: 242.8 million

Links: